Tocilizumab in COVID-19 therapy: who benefits, and how?

ABSTRACT:

SUBMITTER: Neumann AU 

PROVIDER: S-EPMC8298010 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature